An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
Jurij Hanžel(University of Ljubljana), Christopher Ma(University of Calgary), Remo Panaccione(University of Calgary), Walter Reinisch(Medical University of Vienna), Linda J. Cornfield, Maia Kayal(Icahn School of Medicine at Mount Sinai), Vineet Ahuja(All India Institute of Medical Sciences), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Çharles N. Bernstein(University of Manitoba), Rupert W. Leong(The University of Sydney), Peter Bossuyt(Imelda Hospital), Parambir S. Dulai(Northwestern Medicine), William J. Sandborn(University of San Diego), Virginia Solitano(Western University), Ryan C. Ungaro(Feinstein Institute for Medical Research), Torsten Kucharzik(Klinikum Lüneburg), Raja Atreya(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vipul Jairath(McMaster University), Ferdinando D’Amico(Humanitas University), Siddharth Singh(Mayo Clinic in Arizona), Richard B. Gearry(Waitaki Biosciences (New Zealand)), Neeraj Narula(McMaster University), Julián Panés(Hospital Clínic de Barcelona), Ailsa Hart(St Mark's Hospital), Axel Dignaß(Goethe University Frankfurt), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Silvio Danese(IRCCS Ospedale San Raffaele), Brian G. Feagan(Western University), Matthieu Allez(Inserm), David T. Rubin(University of California System), Fernando Magro(Universidade do Porto), Geert D’Haens(Amsterdam University Medical Centers), Tim Raine(National Health Service), Brian Bressler(University of British Columbia), Phillip Fleshner(Cedars-Sinai Medical Center), Édouard Louis(Centre Hospitalier Universitaire de Liège), Takayuki Yamamoto(Yokkaichi Social Insurance Hospital), Marla Dubinsky(Cedars-Sinai Medical Center), Benjamin L. Cohen(Cleveland Clinic), A. Hillary Steinhart(Mount Sinai Hospital), Malcolm Hogan, Miguel Regueiro(University of Pittsburgh Medical Center), Zhihua Ran(Shanghai Jiao Tong University), C. Janneke van der Woude(Radboud University Nijmegen), Sudheer K. Vuyyuru(All India Institute of Medical Sciences), Stephen B. Hanauer(Northwestern University), Jean–Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Robert V. Bryant(Queen Elizabeth Hospital), Simon Travis(University of Oxford), Péter L. Lakatos(McGill University)
Cited by 7
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k